期刊文献+

老年原发性高血压患者血糖及脂质改变对微量白蛋白尿的影响 被引量:4

The primary factors influencing micro-albuminuria in aged hypertensives
原文传递
导出
摘要 目的 :探讨老年原发性高血压 (EH)患者微量白蛋白尿 (MAU )的主要影响因素及其意义。方法 :选择不伴有糖尿病及原发性肾脏疾病的老年 EH患者 81例 ,采用放射免疫法测定早晨第 1次尿中微量白蛋白 ,将其分为 MAU阳性及阴性两组 ,并对所有患者测定血清脂质各项指标、空腹血糖 (FBG)、血胰岛素 (FIns)及 C肽(FC- P) ,计算胰岛素敏感性指数 (ISI) ,进行统计分析。结果 :EH伴 MAU阳性组血清甘油三酯 (TG) (2 .35±1.2 3) mm ol/ L、低密度脂蛋白胆固醇 (L DL- C) (3.89± 1.78) mmol/ L、载脂蛋白 B(apo B) (12 8± 5 3) m mol/ L、脂蛋白 (a)〔L p(a)〕(30 7.13± 196 ) m mol/ L 显著增高 (P <0 .0 5 ,P <0 .0 1)。而高密度脂蛋白胆固醇 (HDL- C) (1.2 2± 0 .2 0 ) m mol/ L、载脂蛋白 A(apo A ) (137.2 2± 10 4) mm ol/ L较低 (P <0 .0 5 )。 ISI(- 4.71± 0 .5 2 )显著低于MAU阴性组 (NMAU ) (P <0 .0 5 )。结论 :在不伴有糖尿病及原发性肾脏疾病的 EH患者中 ,脂质代谢紊乱及胰岛素抵抗可能在 MAU的发生过程中有一定作用。 Objective:To investigate the primary factors influencing micro albuminuria (MAU) in aged hypertensives.Method:81 aged hypertensives without diabetes and primary kidney disease were included in this study.Radioimmunoassay was employed to determine MAU in first urine in the morning.Based on above result,the patients were divided into two groups:MAU group and NMAU group.The important index of serum lipid、FBG、FIns and FC P were determined and the insulin index (ISI) was calculated at the same time.Result:There were significant increase of TG,LDL C,apoB,Lp(a) (P< 0.01 ) and marked decrease of HDL C、apoA in MAU group (P< 0.05 ).Conclusion:This study suggests that the increase of TG,LDL C,apoB,Lp(a) and decrease of HDL C,apoA in aged hyperpietics without diabetes and primary kidney disease may play an important role in the pathogenesis of MAU.
出处 《临床心血管病杂志》 CSCD 北大核心 2000年第6期262-263,共2页 Journal of Clinical Cardiology
关键词 原发性高血压 白蛋白尿 血糖 脂质改变 Essential hypertension Albuminuria Hyperlipemia Insulin resistance
  • 相关文献

参考文献1

共引文献2124

同被引文献19

  • 1成威,周胜华,张铭,李旭平.阿托伐他汀对高血压肾病蛋白尿及C-反应蛋白和白介素-6的影响[J].高血压杂志,2005,13(12):767-770. 被引量:43
  • 2[2]Hiratsuka N,Shiba K,Nishide K,et al.Analysis of urinary albumin,transferring,N-acetylbeta-D-glucosaminidase and beta 2-microglobulin in patients with impaired glucose tolerance.J Clin Lab Anal 1998;12(6):351~353
  • 3[4]Grundy SM.Consensus statement:Role of therapy with "statins" in patients with hypertriglyceridemia.Am J Cardiol 1998;81 (4A):1B~6B
  • 4Shah S,Paparello J,Danesh FR.Effects of statin therapy on the progression of chronic kidney disease.Adv Chronic Kidney Dis,2005,12(2):187-195.
  • 5Masehio G,Alberti D,Janin G,et al.Effect of the angiotensinconverting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency.New Eng J Med,1996,334(9):935-945.
  • 6沈来龙.高血压病患者尿微量蛋白检测及其临床意义B151.全国心血病学术会议,2000.
  • 7Hiratsuka N, Shiba K, Nishide K, et al. Analysis of urinary albumin, transferring, N- acetylbeta - D - glucosaminidase and beta 2- microglobulin in patients with impaired glucose tolerance. J Clin Lab Anal, 1998,12(6) :351 - 353.
  • 8Grundy SM. Consensus statement:Role of therapy with“statins” in patients with hypertriglyceridemia. Am J Cardiol, 1998, 81 (4A) : 1B - 6B.
  • 9Maschio G,Alberti D,Janin G,et al.Effect of the angiotensinconverting-enzyme inhibitor Benazepril on the progression of chronicrenal insufficiency. New England Journal of Homeopathy . 1996
  • 10Samir Shah,James Paparello,Farhad R. Danesh.??Effects of statin therapy on the progression of chronic kidney disease(J)Advances in Chronic Kidney Disease . 2005 (2)

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部